India, June 8 -- Consider a temperature-sensitive biologic moving from a manufacturing hub to a hospital in a Tier II city. It may pass through three or four storage points, two logistics partners, and any number of handling environments before it reaches a patient. At each of those transitions, what matters is not just how the medicine was made, it is how it was carried, stored, and watched over.

India's pharmaceutical reputation has been built, rightly, on the strength of its manufacturing. But the industry is at a turning point. The products leading the next phase of growth demand something more.

India exported pharmaceutical products worth $30.47 billion in FY25, reinforcing its position as one of the world's leading suppliers of me...